Nootropil
Active ingredient: Piracetam
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Nootropil is used in selected neurological conditions, including cortical myoclonus. Its active ingredient may support neuronal function and communication, with treatment tailored to kidney function and individual response.
Product information
Piracetam, the active ingredient of Nootropil, is a nootropic medicine used in selected neurological conditions, including cortical myoclonus. It may support neuronal function and communication, while the appropriate dose depends on the condition, strength, kidney function, and individual response.
How it affects the body
Piracetam changes neuronal membrane function and influences the physical properties of cell membranes. Laboratory research also suggests effects on neurotransmission, microcirculation, and the ability of nerve cells to maintain communication under stress. The precise clinical mechanism is not fully established.
The medicine does not work by directly increasing dopamine in the way stimulant medicines do. It also does not block serotonin reuptake like an SSRI antidepressant. Its action is better described as modulation of neuronal signalling and membrane function rather than a single receptor effect.
For cortical myoclonus, treatment is aimed at reducing the abnormal muscle jerks associated with excessive cortical excitability. The response can differ substantially between patients. The condition itself, other neurological medicines, kidney function, and adherence all influence the result.
Ingredients
Nootropil contains piracetam, a cyclic derivative of gamma-aminobutyric acid (GABA) classified as a nootropic agent. It is supplied as oral capsules. Piracetam does not act like a conventional sedative, stimulant, antidepressant, or painkiller.
Its clinical use depends on the diagnosis. In some treatment settings, piracetam is used as part of therapy for cortical myoclonus, a neurological disorder involving sudden, brief muscle jerks. The medicine has also been studied in several cognitive and neurological conditions, although evidence and approved indications vary between national authorities.
Piracetam crosses the blood–brain barrier and is eliminated mainly through the kidneys. Kidney function therefore has a direct effect on how long the medicine remains in the body. The European Medicines Agency reviewed piracetam-containing medicines in relation to differences in evidence and approved uses across Europe [1].
A practical point is easy to miss: Nootropil is not designed to produce an immediate feeling of stimulation. Some patients notice no subjective sensation even when the medicine is being used for a defined neurological purpose.
Dosage and administration
Nootropil capsules are taken by mouth. The prescribed amount differs between strengths and between users, so there is no single dose that suits everyone.
The treatment plan may depend on:
- The neurological condition being treated.
- The severity and frequency of symptoms.
- Kidney function and age.
- Other medicines taken at the same time.
- The patient’s response and tolerability.
- Whether treatment is being started, adjusted, or continued.
Swallow the capsules with water. Take them at consistent times each day when a regular schedule has been prescribed. Do not open, crush, or chew capsules unless a prescriber has specifically provided different instructions for that formulation.
Nootropil is usually used as part of an ongoing treatment plan rather than as an occasional rescue medicine. Stopping suddenly can allow the original neurological symptoms to return, especially when the medicine is being used for cortical myoclonus. Any planned reduction should follow a clinician’s instruction.
If a dose is missed, take it when remembered unless the next scheduled dose is close. In that situation, skip the missed dose and return to the usual schedule. Do not take two doses together to compensate.
Kidney function deserves special attention in older adults. A person may have no obvious kidney symptoms while still having reduced clearance because of age or chronic illness.
When not to use it
Extra caution is needed with:
- A history of intracerebral haemorrhage.
- Active bleeding or a diagnosed bleeding disorder.
- Major surgery or an upcoming invasive procedure.
- Concurrent anticoagulant treatment, including warfarin.
- Antiplatelet treatment, including aspirin or clopidogrel.
- Severe kidney disease or rapidly changing renal function.
- Pregnancy or breastfeeding, when the expected benefit must be weighed against potential risk.
- Older age with several medicines and reduced renal clearance.
Piracetam may interact pharmacodynamically with medicines that influence clotting. This does not mean that every combination is prohibited, but it does mean that bruising, bleeding, and treatment necessity deserve review.
Use during pregnancy should be decided by the prescriber. Piracetam passes into breast milk, so breastfeeding plans also need a specific assessment.
The EMA’s regulatory review highlights the importance of restricting piracetam treatment to appropriate clinical circumstances and assessing patient-specific risks .
When this is not for you
Tell the prescriber about kidney disease, reduced urine output, or a history of bleeding before treatment begins. Extra caution is needed if you take warfarin, aspirin, clopidogrel, or another medicine that affects clotting. People who are pregnant, breastfeeding, preparing for surgery, or who have severe kidney problems need an individual medical assessment.
Possible side effects
Possible adverse effects include nervousness, agitation, irritability, anxiety, sleep disturbance, headache, tremor, dizziness, nausea, abdominal discomfort, diarrhoea, and weight increase. Some people experience drowsiness, while others report restlessness or difficulty sleeping.
The summary of product characteristics for piracetam also describes less frequent reactions such as confusion, hallucinations, depression, weakness, balance problems, and hypersensitivity reactions. Swelling of the face or throat, breathing difficulty, widespread rash, or sudden collapse requires urgent medical attention.
Bleeding risk deserves special care. Piracetam can affect platelet aggregation, so bruising or bleeding may be more concerning in people taking anticoagulants or antiplatelet medicines. People with a history of haemorrhagic stroke or a known bleeding tendency require an individual risk assessment.
Common practical problems include taking the medicine too late in the day and then attributing poor sleep to the neurological condition. Moving the scheduled doses earlier may help some patients, but the timing should remain consistent with the prescribed regimen.
Another detail matters during planned procedures: piracetam may need special review before surgery because of its effect on platelet aggregation. The surgical team should know about it in advance.
Side effects that need prompt medical assessment include:
- Unusual or persistent bleeding.
- Black stools, blood in urine, or vomiting blood.
- Severe confusion or hallucinations.
- Facial swelling, wheezing, or difficulty breathing.
- Sudden severe weakness or loss of coordination.
- A major worsening of jerking movements or other neurological symptoms.
Therapeutic indications
Its clinical use depends on the diagnosis. In some treatment settings, piracetam is used as part of therapy for cortical myoclonus, a neurological disorder involving sudden, brief muscle jerks. The medicine has also been studied in several cognitive and neurological conditions, although evidence and approved indications vary between national authorities.
Comparison
The most useful comparison is by mechanism, not by brand name. Piracetam, levetiracetam, and citicoline have different pharmacological roles and should not be treated as interchangeable.
| Active substance or approach | Main pharmacological role | Clinical distinction |
|---|---|---|
| Piracetam | Nootropic modulation of neuronal membrane function | Used in selected neurological conditions, including cortical myoclonus |
| Levetiracetam | Antiseizure medicine acting mainly through SV2A-related neuronal signalling | Used for defined seizure disorders and selected forms of myoclonus |
| Citicoline | Choline-containing compound involved in phospholipid and neuronal metabolism | Used in some regions as supportive therapy, with different evidence and indications |
Levetiracetam is not simply a stronger form of piracetam. It is an antiseizure medicine with a different target and a different adverse-effect profile. Substitution requires a clinical reason.
Citicoline also belongs to a different pharmacological category. It may be considered in some cognitive or recovery settings, but its role is not identical to piracetam and it should not be used as an automatic replacement.
The European Medicines Agency’s piracetam review supports a cautious approach to indication-specific prescribing rather than treating all reported cognitive benefits as equivalent .
Common mistakes
Several everyday mistakes can reduce the usefulness of treatment or increase risk:
- Treating Nootropil as an occasional energy booster.
- Taking extra capsules after a missed dose.
- Stopping suddenly when symptoms improve.
- Taking late doses that disturb sleep.
- Forgetting to mention aspirin, clopidogrel, warfarin, or another anticoagulant.
- Assuming that a normal-feeling day means the medicine can be stopped.
- Failing to report reduced urine output or a recent kidney problem.
- Starting several new supplements at the same time, making side effects difficult to identify.
- Driving before knowing whether dizziness, drowsiness, or confusion occurs.
- Hiding the medicine from a surgeon or dentist before a procedure.
One useful habit is to keep the dosing schedule beside the daily routine rather than relying only on memory. For example, linking a morning dose with breakfast can help, while taking a late evening dose may worsen sleep in susceptible patients.
A second mistake is judging treatment only by mental alertness. Piracetam may be prescribed for a specific movement disorder, so the relevant outcome may be fewer jerks rather than a noticeable change in energy.
What doctors say
In clinical practice, doctors generally judge Nootropil by the target symptom, not by whether the patient feels more alert after the first capsule. A clear treatment goal might be fewer cortical jerks, improved functional control, or better tolerance of a neurological rehabilitation plan.
A neurologist may ask for a symptom diary. Useful entries include the number of jerks, the time they occur, sleep quality, falls, tremor, and the timing of each dose. This is more informative than a general statement such as “I feel better.”
Kidney function often becomes the deciding factor in older adults. Creatinine-based kidney estimates can change after dehydration, acute illness, or the addition of medicines that affect renal function. A dose that was tolerated months earlier may require review after such a change.
Patients also benefit from realistic expectations. Nootropil does not repair every cause of memory difficulty, does not replace antiseizure treatment when epilepsy is present, and does not guarantee improvement in concentration. A treatment plan should remain linked to a defined neurological objective.
The British National Formulary describes piracetam dosing as indication-dependent and emphasises renal considerations, reinforcing the need for an individual regimen rather than a universal amount [2].
Common questions
What should be discussed with a doctor before starting Nootropil?
The discussion should include the diagnosis, kidney function, bleeding history, planned surgery, pregnancy or breastfeeding, and every medicine that affects clotting. Piracetam’s renal elimination makes kidney status central to dose selection and follow-up. The EMA’s piracetam assessment from 2014 supports indication-specific use rather than treating the medicine as a general cognitive enhancer. A doctor should know about warfarin, direct oral anticoagulants, aspirin, clopidogrel, and previous intracranial bleeding. Report reduced urine output, severe bruising, or a recent hospital admission before treatment begins.
How soon can an effect from Nootropil become noticeable?
The timing depends on the condition being treated, the prescribed regimen, kidney function, and the symptom used to measure response. Some patients notice a change after treatment has been established, while others require longer observation using a symptom diary. The clinical evidence reviewed by the EMA in 2014 does not support one universal onset time for every indication. For cortical myoclonus, the useful marker is usually a change in the frequency or severity of jerks rather than a subjective feeling. Persistent symptoms should be recorded rather than managed by taking extra capsules.
How does Nootropil differ from levetiracetam?
Nootropil contains piracetam, a nootropic agent that modulates neuronal membrane function. Levetiracetam is an antiseizure medicine with a different mechanism involving synaptic vesicle protein SV2A. The two substances are not interchangeable, even when a patient has jerking movements.
The choice depends on the diagnosis, seizure risk, other medicines, kidney function, and the clinician’s treatment objective. The International League Against Epilepsy (ILAE) described antiseizure treatment within a diagnosis-based framework in 2017, rather than as a general approach to all abnormal movements [3]. Changing from one medicine to the other requires a planned regimen.
Can Nootropil be used by people under 18?
Use in children and adolescents depends on the diagnosis, local product information, and specialist supervision. A child should not receive an adult regimen based only on body size or a family member’s prescription. Kidney function, neurological development, and the cause of the symptoms all influence treatment decisions.
The EMA’s 2014 review of piracetam-containing medicines emphasised the need to align use with an authorised indication and adequate clinical evidence . Parents should provide the prescriber with the child’s full medicine and supplement list. Any new behavioural change, sleep disturbance, rash, or worsening of movements should be reported promptly.
What should be done after a missed Nootropil dose?
Take the missed dose when remembered if the next scheduled dose is not close. If the next dose is due soon, omit the missed capsule and continue at the regular time. Do not double the amount.
The British National Formulary (BNF) advised in 2025 that missed-dose decisions should avoid unnecessary dose stacking, especially when adverse effects may increase with excess exposure . Write down the missed dose and note any change in symptoms. Repeated missed doses may need discussion because inconsistent treatment can make the response difficult to assess.
Can Nootropil be taken with food or on an empty stomach?
Piracetam can generally be taken with or without food. Taking the capsules with food may be more comfortable for someone who develops nausea or stomach discomfort. The most useful routine is the one that supports consistent timing without causing digestive symptoms.
Food does not replace the need to follow the prescribed schedule or dose. Avoid changing the timing repeatedly because it can make sleep effects and symptom response harder to interpret. The product information reviewed by the EMA in 2014 describes oral administration and indication-specific dosing rather than one universal meal requirement .
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- European Medicines Agency (2014). Piracetam-containing medicinal products — referral procedure and scientific assessment.
- British National Formulary (2025). Piracetam: medicine monograph and prescribing information.
- International League Against Epilepsy (2017). ILAE classification of seizure types and terminology for clinical use.